Over the years, numerous testimonials from people who have used or continue to use Dr. Tadeusz Podbielski's TP2 preparation have confirmed its positive effects on the cancer treatment<\/b>. Following this, a decision was made to conduct laboratory tests to determine the effect it has on cancer cells.<\/p>\n
Research on the TP2 formulation was carried out under laboratory conditions by the Institute of Immunology and Experimental Therapeutics of the Polish Academy of Sciences Laboratory of Experimental Anticancer Therapy. Cancer cells tested were lung cancer, prostate cancer, ovarian cancer, colorectal cancer and breast cancer.<\/p>\n
Below you will find the results of individual studies showing the effects of TP2 on cancer cells. They show that natural cancer treatment <\/b>is as possible.<\/p>\nCancer treatment without chemo<\/b> - TP2 research summary<\/h2>\n
Tests conducted have clearly shown that the TP2 formulation exhibits about 2-2.5 higher activity compared to its predecessor TP1, in inhibiting the growth of cancer cells (under laboratory conditions). The change is due to the enrichment of the formula with the presence of iron ions and copper.<\/p>\n
The impact of TP2 on cancer treatment <\/b>was tested by applying the agent at various concentrations directly to the cancer cells. The number of cells after treatment with the agent was then compared with the number of control cells that were not affected by TP2. In this way, it was determined what percentage of the preparation was able to inhibit the growth of living cancer cells. The test results given below refer to the preparation applied at a dilution of 1:400.<\/p>\nCancer treatment <\/b>colon<\/h3>\n
Under laboratory conditions, the TP2 preparation was able to inhibit the growth of colon cancer cells by about 97%. This means that the presence of live cancer cells in the sample after treatment with the preparation left only about 3%.<\/p>\n
The TP2 formulation inhibited about 96% of cancer cells under laboratory conditions. Compared to the control sample, this means the presence of only 4% of viable cancer cells.<\/p>\n
In this case, after testing under laboratory conditions, the growth of cancer cells was inhibited by about 78%. This means that about 22% of prostate cancer cells survived compared to the control sample.<\/p>\n
The TP2 preparation, which was used to treat ovarian cancer tumor cells, was able to inhibit their growth by 96% (under laboratory conditions). After the test, about 4% of viable tumor cells remained.<\/p>\n
In this case, under laboratory conditions, the TP2 preparation was also able to inhibit the growth of cancer cells by about 96%. Viable breast cancer cells remained about 4%.<\/p>","protected":false},"excerpt":{"rendered":"